Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1999 Oct;107(Suppl 5):753–765. doi: 10.1289/ehp.99107s5753

Metals and kidney autoimmunity.

P E Bigazzi 1
PMCID: PMC1566251  PMID: 10502542

Abstract

The causes of autoimmune responses leading to human kidney pathology remain unknown. However, environmental agents such as microorganisms and/or xenobiotics are good candidates for that role. Metals, either present in the environment or administered for therapeutic reasons, are prototypical xenobiotics that cause decreases or enhancements of immune responses. In particular, exposure to gold and mercury may result in autoimmune responses to various self-antigens as well as autoimmune disease of the kidney and other tissues. Gold compounds, currently used in the treatment of patients with progressive polyarticular rheumatoid arthritis, can cause a nephrotic syndrome. Similarly, an immune-mediated membranous nephropathy frequently occurred when drugs containing mercury were commonly used. Recent epidemiologic studies have shown that occupational exposure to mercury does not usually result in autoimmunity. However, mercury induces antinuclear antibodies, sclerodermalike disease, lichen planus, or membranous nephropathy in some individuals. Laboratory investigations have confirmed that the administration of gold or mercury to experimental animals leads to autoimmune disease quite similar to that observed in human subjects exposed to these metals. In addition, studies of inbred mice and rats have revealed that a few strains are susceptible to the autoimmune effects of gold and mercury, whereas the majority of inbred strains are resistant. These findings have emphasized the importance of genetic (immunogenetic and pharmacogenetic) factors in the induction of metal-associated autoimmunity. (italic)In vitro(/italic) and (italic)in vivo(/italic) research of autoimmune disease caused by mercury and gold has already yielded valuable information and answered a number of important questions. At the same time it has raised new issues about possible immunostimulatory or immunosuppressive mechanisms of xenobiotic activity. Thus it is evident that investigations of metal-induced renal autoimmunity have the potential to produce new knowledge with relevance to autoimmune disease caused by xenobiotics in general as well as to idiopathic autoimmunity.

Full text

PDF
753

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andres P. IgA-IgG disease in the intestine of Brown-Norway rats ingesting mercuric chloride. Clin Immunol Immunopathol. 1984 Mar;30(3):488–494. doi: 10.1016/0090-1229(84)90034-5. [DOI] [PubMed] [Google Scholar]
  2. Aten J., Bosman C. B., Rozing J., Stijnen T., Hoedemaeker P. J., Weening J. J. Mercuric chloride-induced autoimmunity in the brown Norway rat. Cellular kinetics and major histocompatibility complex antigen expression. Am J Pathol. 1988 Oct;133(1):127–138. [PMC free article] [PubMed] [Google Scholar]
  3. Aten J., Veninga A., Bruijn J. A., Prins F. A., de Heer E., Weening J. J. Antigenic specificities of glomerular-bound autoantibodies in membranous glomerulopathy induced by mercuric chloride. Clin Immunol Immunopathol. 1992 Apr;63(1):89–102. doi: 10.1016/0090-1229(92)90098-9. [DOI] [PubMed] [Google Scholar]
  4. Aten J., Veninga A., Coers W., Sonnenberg A., Timpl R., Claessen N., van Eendenburg J. D., de Heer E., Weening J. J. Autoantibodies to the laminin P1 fragment in HgCl2-induced membranous glomerulopathy. Am J Pathol. 1995 Jun;146(6):1467–1480. [PMC free article] [PubMed] [Google Scholar]
  5. Aten J., Veninga A., De Heer E., Rozing J., Nieuwenhuis P., Hoedemaeker P. J., Weening J. J. Susceptibility to the induction of either autoimmunity or immunosuppression by mercuric chloride is related to the major histocompatibility complex class II haplotype. Eur J Immunol. 1991 Mar;21(3):611–616. doi: 10.1002/eji.1830210312. [DOI] [PubMed] [Google Scholar]
  6. Baginski B. Effect of mercuric chloride on microbicidal activities of human polymorphonuclear leukocytes. Toxicology. 1988 Aug;50(3):247–256. doi: 10.1016/0300-483x(88)90042-x. [DOI] [PubMed] [Google Scholar]
  7. Bardin T., Dryll A., Debeyre N., Ryckewaert A., Legrand L., Marcelli A., Dausset J. HLA system and side effects of gold salts and D-penicillamine treatment of rheumatoid arthritis. Ann Rheum Dis. 1982 Dec;41(6):599–601. doi: 10.1136/ard.41.6.599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Barger B. O., Acton R. T., Koopman W. J., Alarcón G. S. DR antigens and gold toxicity in white rheumatoid arthritis patients. Arthritis Rheum. 1984 Jun;27(6):601–605. doi: 10.1002/art.1780270601. [DOI] [PubMed] [Google Scholar]
  9. Bariety J., Druet P., Laliberte F., Sapin C. Glomerulonephritis with - and 1C-globulin deposits induced in rats by mercuric chloride. Am J Pathol. 1971 Nov;65(2):293–302. [PMC free article] [PubMed] [Google Scholar]
  10. Barr R. D., Rees P. H., Cordy P. E., Kungu A., Woodger B. A., Cameron H. M. Nephrotic syndrome in adult Africans in Nairobi. Br Med J. 1972 Apr 15;2(5806):131–134. doi: 10.1136/bmj.2.5806.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Barr R. D., Woodger B. A., Rees P. H. Levels of mercury in urine correlated with the use of skin lightening creams. Am J Clin Pathol. 1973 Jan;59(1):36–40. doi: 10.1093/ajcp/59.1.36. [DOI] [PubMed] [Google Scholar]
  12. Barregård L., Eneström S., Ljunghusen O., Wieslander J., Hultman P. A study of autoantibodies and circulating immune complexes in mercury-exposed chloralkali workers. Int Arch Occup Environ Health. 1997;70(2):101–106. doi: 10.1007/s004200050193. [DOI] [PubMed] [Google Scholar]
  13. Bernard A. M., Roels H. R., Foidart J. M., Lauwerys R. L. Search for anti-laminin antibodies in the serum of workers exposed to cadmium, mercury vapour or lead. Int Arch Occup Environ Health. 1987;59(3):303–309. doi: 10.1007/BF00377742. [DOI] [PubMed] [Google Scholar]
  14. Bernaudin J. F., Druet E., Belair M. F., Pinchon M. C., Sapin C., Druet P. Extrarenal immune complex type deposits induced by mercuric chloride in the Brown Norway rat. Clin Exp Immunol. 1979 Nov;38(2):265–273. [PMC free article] [PubMed] [Google Scholar]
  15. Bernier J., Brousseau P., Krzystyniak K., Tryphonas H., Fournier M. Immunotoxicity of heavy metals in relation to Great Lakes. Environ Health Perspect. 1995 Dec;103 (Suppl 9):23–34. doi: 10.1289/ehp.95103s923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bigazzi P. E. Autoimmunity and heavy metals. Lupus. 1994 Dec;3(6):449–453. doi: 10.1177/096120339400300604. [DOI] [PubMed] [Google Scholar]
  17. Bigazzi P. E. Autoimmunity induced by chemicals. J Toxicol Clin Toxicol. 1988;26(3-4):125–156. doi: 10.3109/15563658809000343. [DOI] [PubMed] [Google Scholar]
  18. Bridoux F., Badou A., Saoudi A., Bernard I., Druet E., Pasquier R., Druet P., Pelletier L. Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines. J Exp Med. 1997 May 19;185(10):1769–1775. doi: 10.1084/jem.185.10.1769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Charpentier B., Moullot P., Faux N., Manigand G., Fries D. Fonctions lymphocytaires T au cours d'une glomérulonéphrite extramembraneuse induite par une intoxication chronique au mercure. Nephrologie. 1981;2(4):153–157. [PubMed] [Google Scholar]
  20. Contrino J., Kosuda L. L., Marucha P., Kreutzer D. L., Bigazzi P. E. The in vitro effects of mercury on peritoneal leukocytes (PMN and macrophages) from inbred brown Norway and Lewis rats. Int J Immunopharmacol. 1992 Aug;14(6):1051–1059. doi: 10.1016/0192-0561(92)90150-j. [DOI] [PubMed] [Google Scholar]
  21. Contrino J., Marucha P., Ribaudo R., Ference R., Bigazzi P. E., Kreutzer D. L. Effects of mercury on human polymorphonuclear leukocyte function in vitro. Am J Pathol. 1988 Jul;132(1):110–118. [PMC free article] [PubMed] [Google Scholar]
  22. Cárdenas A., Roels H., Bernard A. M., Barbon R., Buchet J. P., Lauwerys R. R., Roselló J., Hotter G., Mutti A., Franchini I. Markers of early renal changes induced by industrial pollutants. I. Application to workers exposed to mercury vapour. Br J Ind Med. 1993 Jan;50(1):17–27. doi: 10.1136/oem.50.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Daum J. R., Shepherd D. M., Noelle R. J. Immunotoxicology of cadmium and mercury on B-lymphocytes--I. Effects on lymphocyte function. Int J Immunopharmacol. 1993 Apr;15(3):383–394. doi: 10.1016/0192-0561(93)90049-5. [DOI] [PubMed] [Google Scholar]
  24. Druet E., Guery J. C., Ayed K., Guilbert B., Avrameas S., Druet P. Characteristics of polyreactive and monospecific IgG anti-laminin autoantibodies in the rat mercury model. Immunology. 1994 Nov;83(3):489–494. [PMC free article] [PubMed] [Google Scholar]
  25. Druet E., Sapin C., Fournie G., Mandet C., Günther E., Druet P. Genetic control of susceptibility to mercury-induced immune nephritis in various strains of rat. Clin Immunol Immunopathol. 1982 Nov;25(2):203–212. doi: 10.1016/0090-1229(82)90183-0. [DOI] [PubMed] [Google Scholar]
  26. Druet E., Sapin C., Günther E., Feingold N., Druet P. Mercuric chloride-induced anti-glomerular basement membrane antibodies in the rat: genetic control. Eur J Immunol. 1977 Jun;7(6):348–351. doi: 10.1002/eji.1830070605. [DOI] [PubMed] [Google Scholar]
  27. Druet P., Pelletier L. Th2 and Th1 autoreactive anti-class II cell lines in the rat suppress or induce autoimmunity. J Autoimmun. 1996 Apr;9(2):221–226. doi: 10.1006/jaut.1996.0027. [DOI] [PubMed] [Google Scholar]
  28. Druet P., Sheela R., Pelletier L. TH1 and TH2 lymphocytes in autoimmunity. Adv Nephrol Necker Hosp. 1996;25:217–241. doi: 10.1111/j.1440-1797.1996.tb00091.x. [DOI] [PubMed] [Google Scholar]
  29. Druet P., Sheela R., Pelletier L. Th1 and Th2 cells in autoimmunity. Chem Immunol. 1996;63:138–170. [PubMed] [Google Scholar]
  30. Ellingsen D. G., Gaarder P. I., Kjuus H. An immunological study of chloralkali workers previously exposed to mercury vapour. APMIS. 1994 Mar;102(3):170–176. doi: 10.1111/j.1699-0463.1994.tb04862.x. [DOI] [PubMed] [Google Scholar]
  31. Esnault V. L., Mathieson P. W., Thiru S., Oliveira D. B., Martin-Lockwood C. Autoantibodies to myeloperoxidase in brown Norway rats treated with mercuric chloride. Lab Invest. 1992 Jul;67(1):114–120. [PubMed] [Google Scholar]
  32. Fowell D., Powrie F., Saoudi A., Seddon B., Heath V., Mason D. The role of subsets of CD4+ T cells in autoimmunity. Ciba Found Symp. 1995;195:173–188. doi: 10.1002/9780470514849.ch12. [DOI] [PubMed] [Google Scholar]
  33. Fung M. C., Bowen D. L. Silver products for medical indications: risk-benefit assessment. J Toxicol Clin Toxicol. 1996;34(1):119–126. doi: 10.3109/15563659609020246. [DOI] [PubMed] [Google Scholar]
  34. Goebel C., Kubicka-Muranyi M., Tonn T., Gonzalez J., Gleichmann E. Phagocytes render chemicals immunogenic: oxidation of gold(I) to the T cell-sensitizing gold(III) metabolite generated by mononuclear phagocytes. Arch Toxicol. 1995;69(7):450–459. doi: 10.1007/s002040050198. [DOI] [PubMed] [Google Scholar]
  35. Goldman M., Druet P., Gleichmann E. TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today. 1991 Jul;12(7):223–227. doi: 10.1016/0167-5699(91)90034-Q. [DOI] [PubMed] [Google Scholar]
  36. Gran J. T., Husby G., Thorsby E. HLA DR antigens and gold toxicity. Ann Rheum Dis. 1983 Feb;42(1):63–66. doi: 10.1136/ard.42.1.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Griem P., Gleichmann E. Das Antirheumatikum Gold: Erwünschte und unerwünschte Wirkungen von Au(I) und Au(II) auf das Immunsystem. Z Rheumatol. 1996 Sep-Oct;55(5):348–358. [PubMed] [Google Scholar]
  38. Griem P., Gleichmann E. Metal ion induced autoimmunity. Curr Opin Immunol. 1995 Dec;7(6):831–838. doi: 10.1016/0952-7915(95)80056-5. [DOI] [PubMed] [Google Scholar]
  39. Griem P., Takahashi K., Kalbacher H., Gleichmann E. The antirheumatic drug disodium aurothiomalate inhibits CD4+ T cell recognition of peptides containing two or more cysteine residues. J Immunol. 1995 Aug 1;155(3):1575–1587. [PubMed] [Google Scholar]
  40. Griem P., Wulferink M., Sachs B., González J. B., Gleichmann E. Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today. 1998 Mar;19(3):133–141. doi: 10.1016/s0167-5699(97)01219-x. [DOI] [PubMed] [Google Scholar]
  41. Hall C. L. Gold nephropathy. Nephron. 1988;50(4):265–272. doi: 10.1159/000185185. [DOI] [PubMed] [Google Scholar]
  42. Hall C. L. The natural course of gold and penicillamine nephropathy: a longterm study of 54 patients. Adv Exp Med Biol. 1989;252:247–256. doi: 10.1007/978-1-4684-8953-8_23. [DOI] [PubMed] [Google Scholar]
  43. Handel M. L. Transcription factors AP-1 and NF-kappa B: where steroids meet the gold standard of anti-rheumatic drugs. Inflamm Res. 1997 Aug;46(8):282–286. doi: 10.1007/s000110050188. [DOI] [PubMed] [Google Scholar]
  44. Hassman R., Solic N., Jasani B., Hall R., McGregor A. M. Immunological events leading to destructive thyroiditis in the AUG rat. Clin Exp Immunol. 1988 Sep;73(3):410–416. [PMC free article] [PubMed] [Google Scholar]
  45. Henry G. A., Jarnot B. M., Steinhoff M. M., Bigazzi P. E. Mercury-induced renal autoimmunity in the MAXX rat. Clin Immunol Immunopathol. 1988 Nov;49(2):187–203. doi: 10.1016/0090-1229(88)90109-2. [DOI] [PubMed] [Google Scholar]
  46. Hinglais N., Druet P., Grossetete J., Sapin C., Bariety J. Ultrastructural study of nephritis induced in Brown Norway rats by mercuric chloride. Lab Invest. 1979 Aug;41(2):150–159. [PubMed] [Google Scholar]
  47. Hirszel P., Michaelson J. H., Dodge K., Yamase H., Bigazzi P. E. Mercury-induced autoimmune glomerulonephritis in inbred rats. II. Immunohistopathology, histopathology and effects of prostaglandin administration. Surv Synth Pathol Res. 1985;4(5-6):412–422. [PubMed] [Google Scholar]
  48. Hollinger M. A. Toxicological aspects of topical silver pharmaceuticals. Crit Rev Toxicol. 1996 May;26(3):255–260. doi: 10.3109/10408449609012524. [DOI] [PubMed] [Google Scholar]
  49. Hostýnek J. J. Gold: an allergen of growing significance. Food Chem Toxicol. 1997 Aug;35(8):839–844. doi: 10.1016/s0278-6915(97)00058-6. [DOI] [PubMed] [Google Scholar]
  50. Hultman P., Bell L. J., Eneström S., Pollard K. M. Murine susceptibility to mercury. I. Autoantibody profiles and systemic immune deposits in inbred, congenic, and intra-H-2 recombinant strains. Clin Immunol Immunopathol. 1992 Nov;65(2):98–109. doi: 10.1016/0090-1229(92)90212-7. [DOI] [PubMed] [Google Scholar]
  51. Hultman P., Eneström S. Dose-response studies in murine mercury-induced autoimmunity and immune-complex disease. Toxicol Appl Pharmacol. 1992 Apr;113(2):199–208. doi: 10.1016/0041-008x(92)90115-9. [DOI] [PubMed] [Google Scholar]
  52. Hultman P., Eneström S. Mercury induced B-cell activation and antinuclear antibodies in mice. J Clin Lab Immunol. 1989 Mar;28(3):143–150. [PubMed] [Google Scholar]
  53. Hultman P., Eneström S. Mercury induced antinuclear antibodies in mice: characterization and correlation with renal immune complex deposits. Clin Exp Immunol. 1988 Feb;71(2):269–274. [PMC free article] [PubMed] [Google Scholar]
  54. Hultman P., Eneström S., Pollard K. M., Tan E. M. Anti-fibrillarin autoantibodies in mercury-treated mice. Clin Exp Immunol. 1989 Dec;78(3):470–477. [PMC free article] [PubMed] [Google Scholar]
  55. Hultman P., Eneström S. The induction of immune complex deposits in mice by peroral and parenteral administration of mercuric chloride: strain dependent susceptibility. Clin Exp Immunol. 1987 Feb;67(2):283–292. [PMC free article] [PubMed] [Google Scholar]
  56. Hultman P., Eneström S., Turley S. J., Pollard K. M. Selective induction of anti-fibrillarin autoantibodies by silver nitrate in mice. Clin Exp Immunol. 1994 May;96(2):285–291. doi: 10.1111/j.1365-2249.1994.tb06555.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Hultman P., Ganowiak K., Turley S. J., Pollard K. M. Genetic susceptibility to silver-induced anti-fibrillarin autoantibodies in mice. Clin Immunol Immunopathol. 1995 Dec;77(3):291–297. doi: 10.1006/clin.1995.1155. [DOI] [PubMed] [Google Scholar]
  58. Hultman P., Johansson U., Turley S. J., Lindh U., Eneström S., Pollard K. M. Adverse immunological effects and autoimmunity induced by dental amalgam and alloy in mice. FASEB J. 1994 Nov;8(14):1183–1190. doi: 10.1096/fasebj.8.14.7958626. [DOI] [PubMed] [Google Scholar]
  59. Hultman P., Lindh U., Hörsted-Bindslev P. Activation of the immune system and systemic immune-complex deposits in Brown Norway rats with dental amalgam restorations. J Dent Res. 1998 Jun;77(6):1415–1425. doi: 10.1177/00220345980770060601. [DOI] [PubMed] [Google Scholar]
  60. Hultman P., Turley S. J., Eneström S., Lindh U., Pollard K. M. Murine genotype influences the specificity, magnitude and persistence of murine mercury-induced autoimmunity. J Autoimmun. 1996 Apr;9(2):139–149. doi: 10.1006/jaut.1996.0017. [DOI] [PubMed] [Google Scholar]
  61. Ilbäck N. G., Sundberg J., Oskarsson A. Methyl mercury exposure via placenta and milk impairs natural killer (NK) cell function in newborn rats. Toxicol Lett. 1991 Oct;58(2):149–158. doi: 10.1016/0378-4274(91)90169-7. [DOI] [PubMed] [Google Scholar]
  62. Johansson U., Hansson-Georgiadis H., Hultman P. The genotype determines the B cell response in mercury-treated mice. Int Arch Allergy Immunol. 1998 Aug;116(4):295–305. doi: 10.1159/000023959. [DOI] [PubMed] [Google Scholar]
  63. Jones G., Brooks P. M. Injectable gold compounds: an overview. Br J Rheumatol. 1996 Nov;35(11):1154–1158. doi: 10.1093/rheumatology/35.11.1154. [DOI] [PubMed] [Google Scholar]
  64. Katz A., Little A. H. Gold nephropathy. An immunopathologic study. Arch Pathol. 1973 Aug;96(2):133–136. [PubMed] [Google Scholar]
  65. Kean W. F., Hart L., Buchanan W. W. Auranofin. Br J Rheumatol. 1997 May;36(5):560–572. doi: 10.1093/rheumatology/36.5.560. [DOI] [PubMed] [Google Scholar]
  66. Kilburn K. H., Warshaw R. H. Prevalence of symptoms of systemic lupus erythematosus (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water. Environ Res. 1992 Feb;57(1):1–9. doi: 10.1016/s0013-9351(05)80014-3. [DOI] [PubMed] [Google Scholar]
  67. Kimata H., Shinomiya K., Mikawa H. Selective enhancement of human IgE production in vitro by synergy of pokeweed mitogen and mercuric chloride. Clin Exp Immunol. 1983 Jul;53(1):183–191. [PMC free article] [PubMed] [Google Scholar]
  68. Kirchner J., Stein A., Viel K., Jacobi V. Hamman-Rich-Syndrom bei einem Goldschmied. Aktuelle Radiol. 1997 Nov;7(6):321–323. [PubMed] [Google Scholar]
  69. Kono D. H., Balomenos D., Pearson D. L., Park M. S., Hildebrandt B., Hultman P., Pollard K. M. The prototypic Th2 autoimmunity induced by mercury is dependent on IFN-gamma and not Th1/Th2 imbalance. J Immunol. 1998 Jul 1;161(1):234–240. [PubMed] [Google Scholar]
  70. Kosty M. P., Hench P. K., Tani P., McMillan R. Thrombocytopenia associated with auranofin therapy: evidence for a gold-dependent immunologic mechanism. Am J Hematol. 1989 Apr;30(4):236–239. doi: 10.1002/ajh.2830300409. [DOI] [PubMed] [Google Scholar]
  71. Kosuda L. L., Greiner D. L., Bigazzi P. E. Effects of HgCl2 on the expression of autoimmune responses and disease in diabetes-prone (DP) BB rats. Autoimmunity. 1997;26(3):173–187. doi: 10.3109/08916939708994739. [DOI] [PubMed] [Google Scholar]
  72. Kosuda L. L., Greiner D. L., Bigazzi P. E. Mercury-induced renal autoimmunity in BN-->LEW.1N chimeric rats. Cell Immunol. 1994 Apr 15;155(1):77–94. doi: 10.1006/cimm.1994.1103. [DOI] [PubMed] [Google Scholar]
  73. Kosuda L. L., Hannigan M. O., Bigazzi P. E., Leif J. H., Greiner D. L. Thymus atrophy and changes in thymocyte subpopulations of BN rats with mercury-induced renal autoimmune disease. Autoimmunity. 1996;23(2):77–89. doi: 10.3109/08916939608995331. [DOI] [PubMed] [Google Scholar]
  74. Kosuda L. L., Wayne A., Nahounou M., Greiner D. L., Bigazzi P. E. Reduction of the RT6.2+ subset of T lymphocytes in brown Norway rats with mercury-induced renal autoimmunity. Cell Immunol. 1991 Jun;135(1):154–167. doi: 10.1016/0008-8749(91)90262-a. [DOI] [PubMed] [Google Scholar]
  75. Kosuda L. L., Whalen B., Greiner D. L., Bigazzi P. E. Mercury-induced autoimmunity in Brown Norway rats: kinetics of changes in RT6+ T lymphocytes correlated with IgG isotypes of circulating autoantibodies to laminin 1. Toxicology. 1998 Feb 6;125(2-3):215–231. doi: 10.1016/s0300-483x(97)00180-7. [DOI] [PubMed] [Google Scholar]
  76. Kreiss K., Miller F., Newman L. S., Ojo-Amaize E. A., Rossman M. D., Saltini C. Chronic beryllium disease--from the workplace to cellular immunology, molecular immunogenetics, and back. Clin Immunol Immunopathol. 1994 May;71(2):123–129. doi: 10.1006/clin.1994.1061. [DOI] [PubMed] [Google Scholar]
  77. LEE J. C., DUSHKIN M., EYRING E. J., ENGLEMAN E. P., HOPPER J., Jr RENAL LESIONS ASSOCIATED WITH GOLD THERAPY; LIGHT AND ELECTRON MICROSCOPIC STUDIES. Arthritis Rheum. 1965 Feb;8:1–13. doi: 10.1002/art.1780080102. [DOI] [PubMed] [Google Scholar]
  78. Langworth S., Elinder C. G., Sundquist K. G., Vesterberg O. Renal and immunological effects of occupational exposure to inorganic mercury. Br J Ind Med. 1992 Jun;49(6):394–401. doi: 10.1136/oem.49.6.394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Langworth S., Elinder C. G., Sundqvist K. G. Minor effects of low exposure to inorganic mercury on the human immune system. Scand J Work Environ Health. 1993 Dec;19(6):405–413. doi: 10.5271/sjweh.1454. [DOI] [PubMed] [Google Scholar]
  80. Malamud D., Dietrich S. A., Shapiro I. M. Low levels of mercury inhibit the respiratory burst in human polymorphonuclear leukocytes. Biochem Biophys Res Commun. 1985 May 16;128(3):1145–1151. doi: 10.1016/0006-291x(85)91060-5. [DOI] [PubMed] [Google Scholar]
  81. Mason D., Powrie F. Control of immune pathology by regulatory T cells. Curr Opin Immunol. 1998 Dec;10(6):649–655. doi: 10.1016/s0952-7915(98)80084-8. [DOI] [PubMed] [Google Scholar]
  82. Mathieson P. W., Gillespie K. M. Cloning of a partial cDNA for rat interleukin-12 (IL-12) and analysis of IL-12 expression in vivo. Scand J Immunol. 1996 Jul;44(1):11–14. doi: 10.1046/j.1365-3083.1996.d01-279.x. [DOI] [PubMed] [Google Scholar]
  83. Mathieson P. W. Mercuric chloride-induced autoimmunity. Autoimmunity. 1992;13(3):243–247. doi: 10.3109/08916939209004830. [DOI] [PubMed] [Google Scholar]
  84. Mathieson P. W. Mercury: god of Th2 cells? Clin Exp Immunol. 1995 Nov;102(2):229–230. doi: 10.1111/j.1365-2249.1995.tb03769.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Mathieson P. W., Thiru S., Oliveira D. B. Mercuric chloride-treated brown Norway rats develop widespread tissue injury including necrotizing vasculitis. Lab Invest. 1992 Jul;67(1):121–129. [PubMed] [Google Scholar]
  86. Merchant B. Gold, the noble metal and the paradoxes of its toxicology. Biologicals. 1998 Mar;26(1):49–59. doi: 10.1006/biol.1997.0123. [DOI] [PubMed] [Google Scholar]
  87. Monestier M., Losman M. J., Novick K. E., Aris J. P. Molecular analysis of mercury-induced antinucleolar antibodies in H-2S mice. J Immunol. 1994 Jan 15;152(2):667–675. [PubMed] [Google Scholar]
  88. Nagi A. H., Alexander F., Barabas A. Z. Gold nephropathy in rats--light and electron microscopic studies. Exp Mol Pathol. 1971 Dec;15(3):354–362. doi: 10.1016/0014-4800(71)90042-6. [DOI] [PubMed] [Google Scholar]
  89. Nagi A. H., Khan A. H. Gold nephropathy in rabbits using an indigenous preparation. A morphological study. Int Urol Nephrol. 1984;16(1):49–59. doi: 10.1007/BF02082703. [DOI] [PubMed] [Google Scholar]
  90. Obel N., Hansen B., Christensen M. M., Nielsen S. L., Rungby J. Methyl mercury, mercuric chloride, and silver lactate decrease superoxide anion formation and chemotaxis in human polymorphonuclear leucocytes. Hum Exp Toxicol. 1993 Sep;12(5):361–364. doi: 10.1177/096032719301200503. [DOI] [PubMed] [Google Scholar]
  91. Ochel M., Vohr H. W., Pfeiffer C., Gleichmann E. IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol. 1991 May 1;146(9):3006–3011. [PubMed] [Google Scholar]
  92. Pedersen-Bjergaard U., Andersen M., Hansen P. B. Thrombocytopenia induced by noncytotoxic drugs in Denmark 1968-91. J Intern Med. 1996 Jun;239(6):509–515. doi: 10.1046/j.1365-2796.1996.486822000.x. [DOI] [PubMed] [Google Scholar]
  93. Pelletier L., Galceran M., Pasquier R., Ronco P., Verroust P., Bariety J., Druet P. Down modulation of Heymann's nephritis by mercuric chloride. Kidney Int. 1987 Aug;32(2):227–232. doi: 10.1038/ki.1987.196. [DOI] [PubMed] [Google Scholar]
  94. Pelletier L., Pasquier R., Hirsch F., Sapin C., Druet P. In vivo self-reactivity of mononuclear cells to T cells and macrophages exposed to HgCl2. Eur J Immunol. 1985 May;15(5):460–465. doi: 10.1002/eji.1830150509. [DOI] [PubMed] [Google Scholar]
  95. Pelletier L., Pasquier R., Rossert J., Druet P. HgCl2 induces nonspecific immunosuppression in Lewis rats. Eur J Immunol. 1987 Jan;17(1):49–54. doi: 10.1002/eji.1830170109. [DOI] [PubMed] [Google Scholar]
  96. Pelletier L., Rossert J., Pasquier R., Villarroya H., Belair M. F., Vial M. C., Oriol R., Druet P. Effect of HgCl2 on experimental allergic encephalomyelitis in Lewis rats. HgCl2-induced down-modulation of the disease. Eur J Immunol. 1988 Feb;18(2):243–247. doi: 10.1002/eji.1830180210. [DOI] [PubMed] [Google Scholar]
  97. Peszkowski M. J., Warfvinge G., Larsson A. HgCl2-induced glandular pathosis in the brown Norway rat. Clin Immunol Immunopathol. 1993 Dec;69(3):272–277. doi: 10.1006/clin.1993.1180. [DOI] [PubMed] [Google Scholar]
  98. Pietsch P., Vohr H. W., Degitz K., Gleichmann E. Immunological alterations inducible by mercury compounds. II. HgCl2 and gold sodium thiomalate enhance serum IgE and IgG concentrations in susceptible mouse strains. Int Arch Allergy Appl Immunol. 1989;90(1):47–53. [PubMed] [Google Scholar]
  99. Pocino M., Malavé I., Baute L. Zinc administration restores the impaired immune response observed in mice receiving excess copper by oral route. Immunopharmacol Immunotoxicol. 1990;12(4):697–713. doi: 10.3109/08923979009019685. [DOI] [PubMed] [Google Scholar]
  100. Pollard K. M., Lee D. K., Casiano C. A., Bluthner M., Johnston M. M., Tan E. M. The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties. J Immunol. 1997 Apr 1;158(7):3521–3528. [PubMed] [Google Scholar]
  101. Prigent P., Poncet P., Aten J., Blanpied C., Chand A., Février M., Druet P., Hirsch F. Mercuric chloride-induced programmed cell death of a murine T cell hybridoma. II. Opposite effect of interleukin-2 and interleukin-4. Cell Immunol. 1995 Mar;161(1):107–111. doi: 10.1006/cimm.1995.1014. [DOI] [PubMed] [Google Scholar]
  102. Prouvost-Danon A., Abadie A., Sapin C., Bazin H., Druet P. Induction of IgE synthesis and potentiation of anti-ovalbumin IgE antibody response by HgCl2 in the rat. J Immunol. 1981 Feb;126(2):699–792. [PubMed] [Google Scholar]
  103. Qasim F. J., Thiru S., Gillespie K. Gold and D-penicillamine induce vasculitis and up-regulate mRNA for IL-4 in the Brown Norway rat: support for a role for Th2 cell activity. Clin Exp Immunol. 1997 Jun;108(3):438–445. doi: 10.1046/j.1365-2249.1997.2971296.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Qasim F. J., Thiru S., Mathieson P. W., Oliveira D. B. The time course and characterization of mercuric chloride-induced immunopathology in the brown Norway rat. J Autoimmun. 1995 Apr;8(2):193–208. doi: 10.1006/jaut.1995.0015. [DOI] [PubMed] [Google Scholar]
  105. Quarenghi M. I., Del Vecchio L., Casartelli D., Manunta P., Rossi R. MPO antibody-positive vasculitis in a patient with psoriatic arthritis and gold-induced membranous glomerulonephritis. Nephrol Dial Transplant. 1998 Aug;13(8):2104–2106. doi: 10.1093/ndt/13.8.2104. [DOI] [PubMed] [Google Scholar]
  106. Reardon C. L., Lucas D. O. Heavy-metal mitogenesis: Zn++ and Hg++ induce cellular cytotoxicity and interferon production in murine T lymphocytes. Immunobiology. 1987 Nov;175(5):455–469. doi: 10.1016/S0171-2985(87)80073-6. [DOI] [PubMed] [Google Scholar]
  107. Reuter R., Tessars G., Vohr H. W., Gleichmann E., Lührmann R. Mercuric chloride induces autoantibodies against U3 small nuclear ribonucleoprotein in susceptible mice. Proc Natl Acad Sci U S A. 1989 Jan;86(1):237–241. doi: 10.1073/pnas.86.1.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Robinson C. J., Abraham A. A., Balazs T. Induction of anti-nuclear antibodies by mercuric chloride in mice. Clin Exp Immunol. 1984 Nov;58(2):300–306. [PMC free article] [PubMed] [Google Scholar]
  109. Robinson C. J., Balazs T., Egorov I. K. Mercuric chloride-, gold sodium thiomalate-, and D-penicillamine-induced antinuclear antibodies in mice. Toxicol Appl Pharmacol. 1986 Nov;86(2):159–169. doi: 10.1016/0041-008x(86)90046-3. [DOI] [PubMed] [Google Scholar]
  110. Robinson C. J., White H. J., Rose N. R. Murine strain differences in response to mercuric chloride: antinucleolar antibodies production does not correlate with renal immune complex deposition. Clin Immunol Immunopathol. 1997 May;83(2):127–138. doi: 10.1006/clin.1997.4336. [DOI] [PubMed] [Google Scholar]
  111. Romagnoli P., Spinas G. A., Sinigaglia F. Gold-specific T cells in rheumatoid arthritis patients treated with gold. J Clin Invest. 1992 Jan;89(1):254–258. doi: 10.1172/JCI115569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Roman-Franco A. A., Turiello M., Albini B., Ossi E., Milgrom F., Andres G. A. Anti-basement membrane antibodies and antigen--antibody complexes in rabbits injected with mercuric chloride. Clin Immunol Immunopathol. 1978 Apr;9(4):464–481. doi: 10.1016/0090-1229(78)90143-5. [DOI] [PubMed] [Google Scholar]
  113. Russell M. A., Langley M., Truett A. P., 3rd, King L. E., Jr, Boyd A. S. Lichenoid dermatitis after consumption of gold-containing liquor. J Am Acad Dermatol. 1997 May;36(5 Pt 2):841–844. doi: 10.1016/s0190-9622(97)70036-7. [DOI] [PubMed] [Google Scholar]
  114. Saegusa J., Yamamoto S., Iwai H., Ueda K. Antinucleolar autoantibody induced in mice by mercuric chloride. Ind Health. 1990;28(1):21–30. doi: 10.2486/indhealth.28.21. [DOI] [PubMed] [Google Scholar]
  115. Salama A., Mueller-Eckhardt C. Immune-mediated blood cell dyscrasias related to drugs. Semin Hematol. 1992 Jan;29(1):54–63. [PubMed] [Google Scholar]
  116. Sapin C., Hirsch F., Delaporte J. P., Bazin H., Druet P. Polyclonal IgE increase after HgCl2 injections in BN and LEW rats: a genetic analysis. Immunogenetics. 1984;20(3):227–236. doi: 10.1007/BF00364205. [DOI] [PubMed] [Google Scholar]
  117. Satoh M., Hamilton K. J., Ajmani A. K., Dong X., Wang J., Kanwar Y. S., Reeves W. H. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane. J Immunol. 1996 Oct 1;157(7):3200–3206. [PubMed] [Google Scholar]
  118. Schiffer R. B., Herndon R. M., Eskin T. Effects of altered dietary trace metals upon experimental allergic encephalomyelitis. Neurotoxicology. 1990 Fall;11(3):443–450. [PubMed] [Google Scholar]
  119. Schiffer R. B., Sunderman F. W., Jr, Baggs R. B., Moynihan J. A. The effects of exposure to dietary nickel and zinc upon humoral and cellular immunity in SJL mice. J Neuroimmunol. 1991 Nov;34(2-3):229–239. doi: 10.1016/0165-5728(91)90134-s. [DOI] [PubMed] [Google Scholar]
  120. Schrallhammer-Benkler K., Ring J., Przybilla B., Meurer M., Landthaler M. Acute mercury intoxication with lichenoid drug eruption followed by mercury contact allergy and development of antinuclear antibodies. Acta Derm Venereol. 1992 Aug;72(4):294–296. [PubMed] [Google Scholar]
  121. Schuhmann D., Kubicka-Muranyi M., Mirtschewa J., Günther J., Kind P., Gleichmann E. Adverse immune reactions to gold. I. Chronic treatment with an Au(I) drug sensitizes mouse T cells not to Au(I), but to Au(III) and induces autoantibody formation. J Immunol. 1990 Oct 1;145(7):2132–2139. [PubMed] [Google Scholar]
  122. Schuppe H. C., Rönnau A. C., von Schmiedeberg S., Ruzicka T., Gleichmann E., Griem P. Immunomodulation by heavy metal compounds. Clin Dermatol. 1998 Jan-Feb;16(1):149–157. doi: 10.1016/s0738-081x(97)00194-6. [DOI] [PubMed] [Google Scholar]
  123. Shankland S. J., Pippin J., Flanagan M., Coats S. R., Nangaku M., Gordon K. L., Roberts J. M., Couser W. G., Johnson R. J. Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kip1. Kidney Int. 1997 Apr;51(4):1088–1099. doi: 10.1038/ki.1997.151. [DOI] [PubMed] [Google Scholar]
  124. Shenker B. J., Berthold P., Rooney C., Vitale L., DeBolt K., Shapiro I. M. Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes. III. Alterations in B-cell function and viability. Immunopharmacol Immunotoxicol. 1993 Jan;15(1):87–112. doi: 10.3109/08923979309066936. [DOI] [PubMed] [Google Scholar]
  125. Shenker B. J., Datar S., Mansfield K., Shapiro I. M. Induction of apoptosis in human T-cells by organomercuric compounds: a flow cytometric analysis. Toxicol Appl Pharmacol. 1997 Apr;143(2):397–406. doi: 10.1006/taap.1997.8111. [DOI] [PubMed] [Google Scholar]
  126. Smith W., Ball G. V. Lung injury due to gold treatment. Arthritis Rheum. 1980 Mar;23(3):351–354. doi: 10.1002/art.1780230315. [DOI] [PubMed] [Google Scholar]
  127. Stein E. C., Schiffer R. B., Hall W. J., Young N. Multiple sclerosis and the workplace: report of an industry-based cluster. Neurology. 1987 Oct;37(10):1672–1677. doi: 10.1212/wnl.37.10.1672. [DOI] [PubMed] [Google Scholar]
  128. Tam V. K., Green J., Schwieger J., Cohen A. H. Nephrotic syndrome and renal insufficiency associated with lithium therapy. Am J Kidney Dis. 1996 May;27(5):715–720. doi: 10.1016/s0272-6386(96)90108-0. [DOI] [PubMed] [Google Scholar]
  129. Tishler M., Nyman J., Wahren M., Yaron M. Anti-Ro (SSA) antibodies in rheumatoid arthritis patients with gold-induced side effects. Rheumatol Int. 1997;17(4):133–135. doi: 10.1007/s002960050023. [DOI] [PubMed] [Google Scholar]
  130. Tournade H., Guery J. C., Pasquier R., Nochy D., Hinglais N., Guilbert B., Druet P., Pelletier L. Experimental gold-induced autoimmunity. Nephrol Dial Transplant. 1991;6(9):621–630. doi: 10.1093/ndt/6.9.621. [DOI] [PubMed] [Google Scholar]
  131. Tournade H., Guery J. C., Pasquier R., Vial M. C., Mandet C., Druet E., Dansette P. M., Druet P., Pelletier L. Effect of the thiol group on experimental gold-induced autoimmunity. Arthritis Rheum. 1991 Dec;34(12):1594–1599. doi: 10.1002/art.1780341219. [DOI] [PubMed] [Google Scholar]
  132. Tubbs R. R., Gephardt G. N., McMahon J. T., Pohl M. C., Vidt D. G., Barenberg S. A., Valenzuela R. Membranous glomerulonephritis associated with industrial mercury exposure. Study of pathogenetic mechanisms. Am J Clin Pathol. 1982 Apr;77(4):409–413. doi: 10.1093/ajcp/77.4.409. [DOI] [PubMed] [Google Scholar]
  133. Tönroth T., Skrifvars B. Gold nephropathy prototype of membranous glomerulonephritis. Am J Pathol. 1974 Jun;75(3):573–590. [PMC free article] [PubMed] [Google Scholar]
  134. Ueda S., Wakashin M., Wakashin Y., Yoshida H., Iesato K., Mori T., Mori Y., Akikusa B., Okuda K. Experimental gold nephropathy in guinea pigs: detection of autoantibodies to renal tubular antigens. Kidney Int. 1986 Feb;29(2):539–548. doi: 10.1038/ki.1986.32. [DOI] [PubMed] [Google Scholar]
  135. Warbrick E. V., Thomas A. L., Coleman J. W. The effects of mercuric chloride on growth, cytokine and MHC class II gene expression in a human leukemic mast cell line. Toxicology. 1995 Dec 15;104(1-3):179–186. doi: 10.1016/0300-483x(95)03146-7. [DOI] [PubMed] [Google Scholar]
  136. Ward P. A., Goldschmidt P., Greene N. D. Suppressive effects of metal salts on leukocyte and fibroblastic function. J Reticuloendothel Soc. 1975 Nov;18(5):313–321. [PubMed] [Google Scholar]
  137. Warfvinge G., Peszkowski M. J., Hultman P., Larsson A. Oral, perioral and systemic pathosis in HgCl2-induced autoimmunity in the BN rat. Eur J Oral Sci. 1997 Apr;105(2):153–161. doi: 10.1111/j.1600-0722.1997.tb00194.x. [DOI] [PubMed] [Google Scholar]
  138. Watanabe I., Whittier F. C., Jr, Moore J., Cuppage F. E. Gold nephropathy. Ultrastructural, fluorescence, and microanalytic studies of two patients. Arch Pathol Lab Med. 1976 Dec;100(12):632–635. [PubMed] [Google Scholar]
  139. Weening J. J., Fleuren G. J., Hoedemaeker P. J. Demonstration of antinuclear antibodies in mercuric chloride-induced glomerulopathy in the rat. Lab Invest. 1978 Oct;39(4):405–411. [PubMed] [Google Scholar]
  140. Weening J. J., Grond J., van der Top D., Hoedemaeker P. J. Identification of the nuclear antigen involved in mercury-induced glomerulopathy in the rat. Invest Cell Pathol. 1980 Apr-Jun;3(2):129–134. [PubMed] [Google Scholar]
  141. Wild L. G., Ortega H. G., Lopez M., Salvaggio J. E. Immune system alteration in the rat after indirect exposure to methyl mercury chloride or methyl mercury sulfide. Environ Res. 1997;74(1):34–42. doi: 10.1006/enrs.1997.3748. [DOI] [PubMed] [Google Scholar]
  142. Wooley P. H., Griffin J., Panayi G. S., Batchelor J. R., Welsh K. I., Gibson T. J. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. N Engl J Med. 1980 Aug 7;303(6):300–302. doi: 10.1056/NEJM198008073030602. [DOI] [PubMed] [Google Scholar]
  143. Yoshida S., Gershwin M. E. Autoimmunity and selected environmental factors of disease induction. Semin Arthritis Rheum. 1993 Jun;22(6):399–419. doi: 10.1016/s0049-0172(05)80032-0. [DOI] [PubMed] [Google Scholar]
  144. Zalewski P. D., Forbes I. J., Valente L., Hurst N. P. Auranofin increases the affinity of phorbol dibutyrate receptors in chronic lymphocytic leukemia cells (B cells). J Immunol. 1987 May 1;138(9):3005–3009. [PubMed] [Google Scholar]
  145. Zdolsek J. M., Söder O., Hultman P. Mercury induces in vivo and in vitro secretion of interleukin-1 in mice. Immunopharmacology. 1994 Nov-Dec;28(3):201–208. doi: 10.1016/0162-3109(94)90055-8. [DOI] [PubMed] [Google Scholar]
  146. al-Balaghi S., Möller E., Möller G., Abedi-Valugerdi M. Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB x NZW)F1 hybrids. Eur J Immunol. 1996 Jul;26(7):1519–1526. doi: 10.1002/eji.1830260717. [DOI] [PubMed] [Google Scholar]
  147. van der Meide P. H., de Labie M. C., Botman C. A., Aten J., Weening J. J. Nitric oxide suppresses IFN-gamma production in the spleen of mercuric chloride-exposed brown Norway rats. Cell Immunol. 1995 Apr 1;161(2):195–206. doi: 10.1006/cimm.1995.1027. [DOI] [PubMed] [Google Scholar]
  148. van der Meide P. H., de Labie M. C., Botman C. A., van Bennekom W. P., Olsson T., Aten J., Weening J. J. Mercuric chloride down-regulates T cell interferon-gamma production in brown Norway but not in Lewis rats; role of glutathione. Eur J Immunol. 1993 Mar;23(3):675–681. doi: 10.1002/eji.1830230316. [DOI] [PubMed] [Google Scholar]
  149. von dem Borne A. E., Pegels J. G., van der Stadt R. J., van der Plas-van Dalen C. M., Helmerhorst F. M. Thrombocytopenia associated with gold therapy: a drug-induced autoimmune disease? Br J Haematol. 1986 Jul;63(3):509–516. doi: 10.1111/j.1365-2141.1986.tb07528.x. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES